A new strain of the coronavirus has emerged, one that has caught hold in London and southern England. Helping to keep the worries in check was the CEO of BioNTech, the German company that developed a coronavirus vaccine with Pfizer. Ugur Sahin said it “is highly likely” that his company’s vaccine can protect against the new variant, though further studies are needed to be sure. The United States has already approved the company’s vaccine for use, and the European Union recently followed suit. Even without the new strain, worries were already high about rising coronavirus counts and deaths in countries around the world.

Source: Daily Sun December 22, 2020 15:00 UTC